We recently compiled a list of the 10 Best Performing Canadian Stocks in 2025. In this article, we are going to take a look ...
The S&P 500 flirted with a record as U.S. stock-market investors returned from a three-day weekend, awaiting minutes from the ...
We recently compiled a list of the 10 Best Performing S&P 500 Stocks So Far in 2025. In this article, we are going to take a ...
The co-chief investment officers at Neuberger Berman see a new dynamic in the stock market as investors move on from inflation worries You have no doubt seen warnings that the U.S. stock market is ...
Stock futures moved higher as investors readied for corporate earnings in a shortened trading week; Intel shares advanced on ...
Oracle Corporation (ORCL) has been a titan of the IT industry for some time now, but with AI becoming the buzzword on ...
Global shares traded mixed on Monday as investors continued to watch economic data and policy moves from U.S. President Donald Trump, as both are likely to impact upcoming central bank moves.
Alphabet, Palo Alto Networks, Dell Technologies, CrowdStrike, Motorola Solutions, Fortinet, and Emerson Electric are the ...
Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results